Avoro Capital Advisors LLC lifted its position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 11.0% during the fourth quarter, Holdings Channel reports. The firm owned 4,355,555 shares of the company’s stock after acquiring an additional 430,555 shares during the period. Avoro Capital Advisors LLC’s holdings in Taysha Gene Therapies were […]
Avoro Capital Advisors LLC boosted its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,858,888 shares of the biotechnology company’s stock after purchasing an additional 6,388 shares during the period. United […]
Avoro Capital Advisors LLC increased its stake in Merus (NASDAQ:MRUS – Free Report) by 100.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 888,888 shares of the biotechnology company’s stock after purchasing an additional 444,444 shares during the quarter. Avoro Capital Advisors LLC’s holdings in Merus were worth $24,444,000 as of its most […]
Bellevue Group AG lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 6.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 325,776 shares of the biotechnology company’s stock after selling 24,112 shares during the quarter. Bellevue Group AG owned approximately 0.17% of […]
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 3,460,000 shares, a decline of 6.5% from the April 30th total of 3,700,000 shares. Based on an average daily volume of 370,500 shares, […]